HeartBeam, Inc. (BEAT)
Nasdaq · Healthcare · Health Information Services
$0.6542+50.53%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $36.9M
- 52-week range
- $0.355 – $4.00
- 52-week change
- −75.28%
- EPS (trailing)
- −$0.50
- Analyst rating
- 2.0 Buy
- Next earnings
- Nov 12, 2026
Fiscal year to Dec 2025
- Net income
- −$21.0M
- Diluted EPS
- −$0.62
- Free cash flow
- −$14.6M
From the company’s annual report on SEC EDGAR.
About HeartBeam, Inc.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Headquarters: Santa Clara, United States · 16 employees · heartbeam.com